DNase I overexpression reduced <i>A3A</i> upregulation upon MeV infection. by Pierre Khalfi (7868252)

Fenugreek exposure decreased the frequency and the alternations of the locomotor like activity. by Loubna Khalki (480082)

Inhibition of TGF-β decreases retinal perfusion and vascular autoregulation. by Tony E. Walshe (269700)

Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

“…<b>(D)</b> The number of recent transposon insertions [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010345#pgen.1010345.ref022" target="_blank">22</a>] as a function of <i>NRPE1’</i> genotype and the number of mCHG-decreasing alleles. …”

Stable knockdown of JTB in HCC cells decreases cell apoptosis. by Yun-Peng Liu (108506)

Myelin decreases ⁵⁵Fe uptake by MDMs. by Veela Mehta (390027)

PTB is associated with decreased antigen-stimulated production of IL-4. by Nathella Pavan Kumar (129299)

Decreased GH storage and secretion in PICK1-deficient mice. by Birgitte Holst (250548)

“…(B) PICK1-deficient mice exhibited a decreased level of plasma IGF-1 (*<i>p</i><0.05). …”

The p.I126S mutation decreases FOXC1 phosphorylation. by Cristina Medina-Trillo (705087)

Treatment with FK506 decreases prion-induced neuronal loss. by Abhisek Mukherjee (240270)

Intrahepatic CXCL9 expression decreases significantly after hepatectomy. by Takuya Yano (415157)

CPSF6 protein expression is decreased in virus-infected cells. by Yong Ge (816832)

HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

Opinion distributions and mean shadow ban strength versus time under shadow banning control policies for different objective functions on a path network. by Yen-Shao Chen (18264587)

Decreased CSF cytokine levels in α7 KO mice. by Feng Chi (170688)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

Silencing of RCC1L isoforms alter the levels of mitochondrial ribosomal proteins and biogenesis factors resulting in decreased mitochondrial translation. by Aurelio Reyes (412135)

Nicotine decreases PDI expression in e15 rat placentas. by Michael K. Wong (646399)

Activated CD4+ CD45RO+ memory T-cells decrease secretion of soluble caspase-1 and P2X7R mRNA expression in monocytes leading to a reduced response upon ATP binding. by Vanessa Beynon (153924)

“…A significant decrease of soluble Caspase-1 in the supernatant of cells co-cultured with activated memory T-cells was observed both in the presence and absence of IFNβ; b) intracellular levels of pro-IL-1β measured with an ELISA specific for the immature precursor of IL-1β showed a significant increase in pro-IL-1β levels in the presence of human activated CD4+CD45RO+ memory T-cells (n = 3), cell lysates from adherent monocytes were obtained after removal of non-adherent T-cells after addition of LPS and prior to incubation with ATP c) the ratio of intracellular pro-IL-1β to released soluble Caspase-1 is significantly increased in the presence of human activated CD4+CD45RO+ memory T-cells (n = 3). d) <i>P2X7R</i> mRNA expression in monocytes cultured overnight with activated CD4+CD45RO+ memory T-cells is decreased with and without addition of exogenous IFNβ (n = 3), mRNA was isolated from adherent monocytes after removal of non-adherent T-cells after addition of LPS and prior to incubation with ATP (Data are shown as means ± SD of duplicate cultures; *p<0.05; **p<0.01 employing repeated measures ANOVA with post-hoc Bonferroni adjustment for multiple comparisons to avoid random correlations); e) Ca²⁺-influx measurement in monocytes cultured with activated human CD4+CD45RO+ memory T-cells in the presence of IFNβ demonstrates the absence of slow sustained Ca²⁺-influx mediated by ATP binding to the purinergic P2X7-receptor (representative of 3 independent experiments); f) Annexin V staining of monocytes coincubated with T-cells and stimulated with LPS was measured by flow cytometry (representative flow cytometry histogram of n = 5).…”

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4 by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”